Japan prosecutors arrest ex-Novartis employee over data

June 11, 2014

Prosecutors on Wednesday arrested a former employee of the Japanese unit of Swiss pharmaceutical giant Novartis for allegedly manipulating research data to exaggerate the benefits of a popular blood-pressure drug.

Nobuo Shirahashi, 63, was arrested for allegedly falsifying data in clinical studies that were then used to promote the blood-pressure drug Valsartan.

Prosecutors raided the offices of Novartis Pharma KK in Tokyo after a university said the data may be skewed.

The studies suggested the drug—sold under the name Diovan in Japan, and licensed for use in more than 100 countries—could help prevent strokes and angina.

The firm used data from the studies to market its , playing up its supposed additional benefits.

There is no suggestion that Diovan is ineffective in combating blood pressure problems.

The pharmaceutical giant's Japan unit has also been embroiled in another scandal in which it was alleged possible side effects of leukaemia treatments had not been properly disclosed.

In April, Novartis replaced top executives at its Japanese arm over the allegations.

Under Japan's law, anyone found guilty of exaggerating advertising can face up to two years in prison or a fine of as much as two million yen ($19,000).

Explore further: Japan prosecutors raid Novartis over drug ad scandal

Related Stories

Japan prosecutors raid Novartis over drug ad scandal

February 19, 2014
Japanese prosecutors on Wednesday raided the offices of the local arm of Swiss pharmaceutical giant Novartis over alleged exaggerated advertising for a popular blood-pressure drug, local media said.

Japan files criminal complaint against Novartis arm

January 9, 2014
Japan's health ministry on Thursday filed a criminal complaint against the local arm of Swiss pharmaceutical giant Novartis over alleged exaggerated advertising for a popular blood-pressure drug, the company said.

Japan to file criminal complaint against Novartis (Update)

January 7, 2014
Japan's health ministry plans to file a criminal complaint against the local arm of Swiss pharmaceutical giant Novartis over alleged exaggerated advertising for a popular blood-pressure drug, an official said Wednesday.

Novartis' top Japan executives quit over cancer drug scandal (Update)

April 3, 2014
Swiss pharmaceutical giant Novartis said Thursday it was replacing the top executives at its Japanese unit over allegations the division hid serious potential side effects of leukaemia treatments from regulators.

Japan to seek criminal prosecution of Novartis

December 18, 2013
Japan's health ministry intends to file a criminal complaint against the local arm of Swiss pharmaceutical giant Novartis over alleged fabrication of drugs data, a report said Wednesday.

Japan university reveals more claims of fabricated drug data

July 31, 2013
A Japanese university Wednesday said it would retract a study that touted the effectiveness of a blood pressure drug made by Swiss pharmaceutical giant Novartis because it was based on fabricated data.

Recommended for you

Patients receive most opioids at the doctor's office, not the ER

January 16, 2018
Around the country, state legislatures and hospitals have tightened emergency room prescribing guidelines for opioids to curb the addiction epidemic, but a new USC study shows that approach diverts attention from the main ...

FDA bans use of opioid-containing cough meds by kids

January 12, 2018
(HealthDay)—Trying to put a dent in the ongoing opioid addiction crisis, the U.S. Food and Drug Administration on Thursday slapped strict new restrictions on the use of opioid-containing cold and cough products by kids.

Taking ibuprofen for long periods found to alter human testicular physiology

January 9, 2018
A team of researchers from Denmark and France has found that taking regular doses of the pain reliever ibuprofen over a long period of time can lead to a disorder in men called compensated hypogonadism. In their paper published ...

Nearly one-third of Canadians have used opioids: study

January 9, 2018
Nearly one in three Canadians (29 percent) have used "some form of opioids" in the past five years, according to data released Tuesday as widespread fentanyl overdoses continue to kill.

Growing opioid epidemic forcing more children into foster care

January 8, 2018
The opioid epidemic has become so severe it's considered a national public health emergency. Addiction to prescription painkillers, such as oxycodone and morphine, has contributed to a dramatic rise in overdose deaths and ...

Price tag on gene therapy for rare form of blindness: $850K

January 3, 2018
A first-of-its kind genetic treatment for blindness will cost $850,000 per patient, making it one of the most expensive medicines in the world and raising questions about the affordability of a coming wave of similar gene-targeting ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.